Table 6.
Exp (b)* | 95% C.I. | p-value† | |
Overall Survival, all patients | |||
Age (1: above median; 0: below median) | 2.21 | 1.33–3.67 | 0.002† |
PTT (1: sarcoma; 0: carcinoma) | 2.65 | 1.57–4.46 | < 0.001† |
Adjuvant therapy (1: yes; 0: no) | 0.69 | 0.43–1.12 | 0.14 |
Recurrence Free Survival, all patients | |||
PTT (1: sarcoma; 0: carcinoma) | 2.76 | 1.68–4.54 | < 0.001† |
Magnitude (1: other, 0: wedge) | 0.54 | 0.29–0.98 | 0.05 |
*Exp (b) = Hazard Ratio
† Two-tailed p-value; < 0.05 considered statistically significant.